Minnesota’s Office of Cannabis Management has issued guidance, dated November 6, 2026, explaining how the state’s medical and adult-use cannabis supply chains will merge on January 1, 2027, under a law passed by the Legislature this year. From that date, a product’s medical or adult-use designation will generally be set at retail sale, except for
Minnesota’s Office of Cannabis Management has issued guidance, dated November 6, 2026, explaining how the state’s medical and adult-use cannabis supply chains will merge on January 1, 2027, under a law passed by the Legislature this year. From that date, a product’s medical or adult-use designation will generally be set at retail sale, except for select high-medical-need products.
Under the memo, retailers with a medical endorsement must carry all high-medical-need products the office has identified and make them available to a registered patient or caregiver within 24 hours of a request. Manufacturers with a medical endorsement must submit a product list by March 1, 2027, and begin making those products by July 1, 2027.
Patients must still enroll in the registry and consult a pharmacist or certified consultant. Enrollment stays valid for three years, and the excise tax exemption for registered patients continues. The office says further guidance is forthcoming.



















